Arrowhead Pharmaceuticals
ARWR
#2278
Rank
HK$64.41 B
Marketcap
HK$456.00
Share price
1.22%
Change (1 day)
47.14%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): -HK$13.32

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$26.11. In 2022 the company made an earnings per share (EPS) of -HK$11.45 an increase over its 2021 EPS that were of -HK$13.80.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$13.3216.34%
2022-HK$11.45-17.05%
2021-HK$13.8074.26%
2020-HK$7.92-283.64%
2019HK$4.31-257.14%
2018-HK$2.74-27.08%
2017-HK$3.76-59.32%
2016-HK$9.25-21.85%
2015-HK$11.849.42%
2014-HK$10.822.87%
2013-HK$10.52-31.56%
2012-HK$15.37300%
2011-HK$3.84-45.56%
2010-HK$7.06-66.67%
2009-HK$21.17-63.51%
2008-HK$58.02-12.94%
2007-HK$66.6444.07%
2006-HK$46.2677.35%
2005-HK$26.0810.66%
2004-HK$23.57-54.25%
2003-HK$51.53-80.51%
2002-HK$264.363.87%
2001-HK$254.51116.17%
2000-HK$117.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41-300.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$62.64 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$78.48-400.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$155.32-694.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$14.35-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA